Publications

Detailed Information

Integration of stem cells and graphene for myocardial infarction treatment : 줄기세포와 그래핀의 융합을 통한 심근경색의 치료

DC Field Value Language
dc.contributor.advisor김병수-
dc.contributor.author박주연-
dc.date.accessioned2017-07-13T08:40:35Z-
dc.date.available2017-07-13T08:40:35Z-
dc.date.issued2015-08-
dc.identifier.other000000049852-
dc.identifier.urihttps://hdl.handle.net/10371/119744-
dc.description학위논문 (박사)-- 서울대학교 대학원 : 화학생물공학부, 2015. 8. 김병수.-
dc.description.abstractMyocardial infarction (MI) is one of the major causes of death worldwide. However, the clinical therapies to treat MI is very limited, and the number of patients increases every year. Therefore, there is an urgent need to develop alternative therapeutic methods for cardiac repair after MI. Recently, stem cell and tissue engineering emerged as a potential strategy for MI treatment. In addition, graphene has also drawn much attention for their application in the field of biomedical engineering due to its unique electrical, chemical, optical, and physical properties.
Therefore, in this dissertation presents the integration of stem cells and graphene for the treatment of MI. The major goals of this study is summarized as follows. 1) Development of a graphene platform to promote stem cell differentiation towards cardiac lineage, and the investigation of its mechanisms. 2) Improvement of stem cell therapy efficacy for MI treatment by utilizing reduced graphene oxide (RGO) to promote paracrine factor secretion and gap junction protein expression by stem cells. 3) Utilizing graphene oxide (GO) flakes to prevent stem cell anoikis when implanted to ischemia and reperfusion injury after MI.
First, we showed that graphene can promote cardiomyogenic differentiation process of mesenchymal stem cells (MSCs). MSCs have drawn much attention as a source of MI therapy because MSCs are easy to isolate and expand, and are capable of differentiating into various cell types. However, the conventional methods to differentiate stem cells to cardiomyocytes require expensive growth factors or toxic chemical inducers. In this study, we demonstrated that the cardiomyogenic differentiation process of MSCs could be promoted simply by culturing MSCs on graphene without using additional inducers for the differentiation. This may be attributed to the enhanced expression of extracellular matrix (ECM) proteins related to cardiomyogenic differentiation. In addition, the signaling molecules required for cardiomyogenic differentiation are upregulated in MSCs cultured on graphene. Collectively, graphene was able to promote cardiomyogenic gene expressions in MSCs.
Second, we showed that the incorporation of RGO flakes into MSC spheroids enhanced the expression of angiogenic growth factors and gap junction proteins in MSCs, and resulted in the attenuation of cardiac remodeling after MI. The secretion of paracrine factors and the formation of gap junctions by the implanted cells promote cardiac repair. The formation of spheroids by MSC clustering is known to promote growth factor secretion by promoting cell-cell interactions. However, cell-ECM interactions, which can further promote growth factor secretion, is very limited in MSC spheroids. Therefore, in this study, we incorporated RGO, which can adsorb ECM proteins, in MSC spheroids to promote cell-ECM interactions. As a result, the secretion of paracrine factors was further enhanced in MSC-RGO hybrid spheroids. The enhanced secretion of paracrine factors by the incorporation of RGO upregulated the gap junction protein expression in MSCs. The implantation of MSC-RGO spheroids promoted cardiac repair compared to the implantation of MSC spheroids.
Finally, the adhesion of GO flakes to MSCs prior to implantation enhanced the therapeutic efficacy of MSCs in MI. The restoration of blood flow after MI results in a burst of reactive oxygen species (ROS). ROS hinders the adhesion of the implanted MSCs to the injured myocardium, resulting in cell anoikis (i.e. cell death due to the loss of adhesion). Therefore, we have protected MSCs from undergoing anoikis by adhering GO flakes to MSCs prior to their implantation to the injured myocardium. GO is capable of effectively adsorbing ECM proteins. ECM protein-adsorbed GO flakes protected MSCs from undergoing anoikis when MSCs-GO were exposed to ROS condition in vitro. In vivo, MSCs-GO showed enhanced engraftment in the reperfused myocardium after MI compared to MSCs alone. The enhanced engraftment of MSCs-GO resulted in enhanced paracrine factor secretion. Therefore, the adhesion of GO flakes to MSCs promoted cardiac tissue repair and cardiac function restoration.
-
dc.description.tableofcontentsAbstract I
Table of contents IV
List of figures VIII
List of tables XI
Abbreviations XII

Chapter 1. Research backgrounds and objectives 1
1.1. Myocardial infarction (MI) 2
1.2. MSCs for MI treatment 4
1.2.1. Differentiation of MSCs into cardiac lineage 7
1.2.2. Paracrine factor secretion of MSCs for cardiac repair 9
1.3. Nanobiomaterial-incorporated stem cell therapy for cardiac repair 11
1.3.1. Therapeutic molecule delivery system 13
1.3.2. Cell delivery vehicle 16
1.3.3. Nanotopographical cues of nanobiomaterials 19
1.3.4. Electrically conductive nanobiomaterials 22
1.3.5. Intrinsic chemistry of nanobiomaterials 25
1.4. Limitations of previous stem cell therapies for MI treatment 27
1.5. Graphene for tissue engineering applications 29
1.6. Research objectives of this dissertation 32
Chapter 2. Experimental procedures 33
2.1. Preparation of graphene and graphene derivatives 34
2.1.1. Graphene preparation 34
2.1.2. GO and RGO preparation 35
2.2. Characterization of graphene and graphene derivatives 36
2.3. Cell preparation 37
2.3.1. MSC culture on graphene-coated coverslips 37
2.3.2. MSC-RGO spheroid formation 38
2.3.3. GO adhesion to MSCs 39
2.4. In vitro assays 40
2.4.1. TEM analyses 40
2.4.2. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). 41
2.4.3. Analyses of cell viability. 43
2.4.4. Enzyme-linked immunosorbent assay (ELISA) 44
2.4.5. Western blot 45
2.4.6. Immunocytochemistry 46
2.4.7. Dye transfer 47
2.4.8. Analyses of GO adhesion on MSCs 48
2.4.9. Assays for cell adhesion and viability with or without GO under reactive oxygen species (ROS) condition 49
2.4.10. Detection of ROS 50
2.4.11. Adhesion of fibronectin (FN)- or vitronectin (VN)- adsorbed GO flakes to MSCs 51
2.4.12. Competition between free ECM proteins and ECM proteins adsorbed on GO for their interactions with MSCs 52
2.5. Experimental procedures in vivo 53
2.5.1. MI induction and MSC-RGO spheroid implantation 53
2.5.2. Induction of MI and MSC-GO implantation 54
2.5.3. Analyses of surviving MSCs 55
2.5.4. Histochemical and immunohistochemical staining. 56
2.5.5. Evaluation of cardiac function 58
2.6. Statistical analyses 59
Chapter 3. Graphene-regulated cardiomyogenic differentiation process of mesenchymal stem cells by enhancing the expression of extracellular matrix proteins and cell signialing molecules 60
3.1. Introduction 61
3.2. Results and discussion 63
3.2.1. Fabrication of graphene 63
3.2.2. Characterization of graphene 65
3.2.3. Biocompatibility of graphene 68
3.2.4. Cardiomyogenic lineage commitment of MSCs cultured on graphene 70
3.2.5. Enhanced ECM gene expression by graphene 73
3.2.6. Regulation of cell signaling pathway by graphene 76
Chapter 4. Graphene potentiates the myocardial repair efficacy of mesenchymal stem cells by stimulating the expression of angiogenic growth factors and gap junction protein 78
4.1. Introduction 79
4.2. Results and discussion 82
4.2.1. Characterization of RGO flakes 82
4.2.2. Formation of MSC-RGO hybrid spheroids 84
4.2.3. Enhanced cell-ECM interactions by RGO incorporation into MSC spheroids 89
4.2.4. Enhanced angiogenic growth factor expression in MSC-RGO spheroids 91
4.2.5. Enhanced Cx43 expression in MSC-RGO spheroids 95
4.2.6. Improved cardiac repair by MSC-RGO hybrid spheroid implantation 98
4.2.7. Improvement in cardiac function by MSC-RGO hybrid spheroid implantation 101
Chapter 5. Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species-mediated death of implanted cells for cardiac repair 102
5.1. Introduction 103
5.2. Results and discussion 106
5.2.1. Characterization of GO flakes 106
5.2.2. GO adhesion on MSCs 108
5.2.3. Enhanced cell adhesion and survival under ROS condition in vitro 111
5.2.4. The mechanism of enhanced cell survival 114
5.2.5. Enhanced survival of MSCs implanted in a myocardial ischemia and reperfusion model 121
5.2.6. Improvement in myocardial repair by MSC-GO 124
Chapter 6. Conclusions 132
References 135
요약 (국문초록) 173
-
dc.formatapplication/pdf-
dc.format.extent4433330 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectmesenchymal stem cells-
dc.subjectgraphene-
dc.subjectmyocardial infarction-
dc.subjectcell function-
dc.subjectcell implantation-
dc.subject.ddc660-
dc.titleIntegration of stem cells and graphene for myocardial infarction treatment-
dc.title.alternative줄기세포와 그래핀의 융합을 통한 심근경색의 치료-
dc.typeThesis-
dc.contributor.AlternativeAuthorJooyeon Park-
dc.description.degreeDoctor-
dc.citation.pagesxiv, 175-
dc.contributor.affiliation공과대학 화학생물공학부-
dc.date.awarded2015-08-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share